The Asia Pacific dialysis access treatment device market will grow modestly through 2029, driven by rising incidence of ESRD due to the aging population, coupled with government initiatives to improve access to dialysis care. However, market growth will be hindered to some extent due to the COVID-19 pandemic.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for dialysis access treatment products in Asia Pacific countries across a 10-year period.
The COVID-19 pandemic will have a negative impact on overall dialysis access procedure volumes and revenues in 2020.
What factors will contribute to the impact on dialysis access treatment device market?
To what degree will the pandemic affect different dialysis access device segments?
How soon will procedure volumes, sales, and revenues recover over the forecast period?
Clinical data and treatment guidelines will drive the use of a particular device.
What clinical trials and clinical studies have been performed in the dialysis access treatment device space?
What will be the impact of the results of the clinical trials being performed?
Price consciousness and inadequate reimbursement represent major limiters for the uptake of premium-priced technologies in the Asia Pacific dialysis access treatment devices.
What effect will varying levels of reimbursement between countries have on their respective markets?
How will cost consciousness among Asia Pacific countries affect device uptake in different product segments?
Growth in the Chinese and Indian markets is being driven in part by government health care reforms in these countries
What government initiatives are currently impacting trends in dialysis access treatment?
How will these initiatives impact the growth of the dialysis access treatment device market?
- Dialysis Access Treatment Devices - Market Insights - Asia Pacific
Author(s): Bishwjit Ghoshal, MBA; Sai Harshita Yangam
Bishwjit Ghoshal is a senior analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.
Follow Bishwjit on twitter: @Bishwjit_DRG